BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30102772)

  • 21. Palmitic acid induces autophagy in hepatocytes via JNK2 activation.
    Tu QQ; Zheng RY; Li J; Hu L; Chang YX; Li L; Li MH; Wang RY; Huang DD; Wu MC; Hu HP; Chen L; Wang HY
    Acta Pharmacol Sin; 2014 Apr; 35(4):504-12. PubMed ID: 24608675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epoxyeicosatrienoic acids alleviate methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in mice.
    Wang X; Li L; Wang H; Xiao F; Ning Q
    Scand J Immunol; 2019 Sep; 90(3):e12791. PubMed ID: 31132306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the macrophage-hepatic stellate cell interaction by targeting macrophage peroxisome proliferator-activated receptor gamma to prevent non-alcoholic steatohepatitis progression in mice.
    Ni XX; Ji PX; Chen YX; Li XY; Sheng L; Lian M; Guo CJ; Hua J
    Liver Int; 2022 Dec; 42(12):2696-2712. PubMed ID: 36165186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
    Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
    World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
    Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
    Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).
    Jindal A; Bruzzì S; Sutti S; Locatelli I; Bozzola C; Paternostro C; Parola M; Albano E
    Exp Mol Pathol; 2015 Aug; 99(1):155-62. PubMed ID: 26112094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIF-1α expression as a protective strategy of HepG2 cells against fatty acid-induced toxicity.
    Yoo W; Noh KH; Ahn JH; Yu JH; Seo JA; Kim SG; Choi KM; Baik SH; Choi DS; Kim TW; Kim HJ; Kim NH
    J Cell Biochem; 2014 Jun; 115(6):1147-58. PubMed ID: 24402912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
    Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y
    J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
    Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
    J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis.
    Zhang X; Shen J; Man K; Chu ES; Yau TO; Sung JC; Go MY; Deng J; Lu L; Wong VW; Sung JJ; Farrell G; Yu J
    J Hepatol; 2014 Dec; 61(6):1365-75. PubMed ID: 25048951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of HIF-1α/BNIP3-mediated autophagy to lipid accumulation during irinotecan-induced liver injury.
    Shi C; Zhang Z; Xu R; Zhang Y; Wang Z
    Sci Rep; 2023 Apr; 13(1):6528. PubMed ID: 37085612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indoleamine 2,3-dioxygenase 1-mediated iron metabolism in macrophages contributes to lipid deposition in nonalcoholic steatohepatitis.
    Wu C; Li J; Jia H; Zhao J; Qin M; Shi H; Liu C; Lin J; Cai M; Gu Y; Liu B; Gao L
    J Gastroenterol; 2024 Apr; 59(4):342-356. PubMed ID: 38402297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynein light chain LC8 alleviates nonalcoholic steatohepatitis by inhibiting NF-κB signaling and reducing oxidative stress.
    Lee GR; Lee HI; Kim N; Lee J; Kwon M; Kang YH; Song HJ; Yeo CY; Jeong W
    J Cell Physiol; 2022 Sep; 237(9):3554-3564. PubMed ID: 35696549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indole supplementation ameliorates MCD-induced NASH in mice.
    Zhu B; Li H; Lu B; Guo X; Wu C; Wang F; Li Q; Xie L; Glaser S; Francis H; Alpini G; Wu C
    J Nutr Biochem; 2022 Sep; 107():109041. PubMed ID: 35568098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis.
    Wang X; Hausding M; Weng SY; Kim YO; Steven S; Klein T; Daiber A; Schuppan D
    Antioxid Redox Signal; 2018 Jan; 28(2):87-109. PubMed ID: 28635324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis.
    Wang T; Sun G; Wang Y; Li S; Zhao X; Zhang C; Jin H; Tian D; Liu K; Shi W; Tian Y; Zhang D
    FASEB J; 2019 Jul; 33(7):8490-8503. PubMed ID: 30951375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid-injured hepatocytes release sOPN to improve macrophage migration via CD44 engagement and pFak-NFκB signaling.
    Jiang X; Zhang F; Ji X; Dong F; Yu H; Xue M; Qiu Y; Yang F; Hu X; Bao Z
    Cytokine; 2021 Jun; 142():155474. PubMed ID: 33647584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitin-specific peptidase 10 ameliorates hepatic steatosis in nonalcoholic steatohepatitis model by restoring autophagic activity.
    Xin SL; Yu YY
    Dig Liver Dis; 2022 Aug; 54(8):1021-1029. PubMed ID: 35288065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency.
    Kim M; Yoo G; Randy A; Kim HS; Nho CW
    Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 27981809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-inducible factor-2 promotes liver fibrosis in non-alcoholic steatohepatitis liver disease via the NF-κB signalling pathway.
    Cai H; Bai Z; Ge RL
    Biochem Biophys Res Commun; 2021 Feb; 540():67-74. PubMed ID: 33450482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.